
Sign up to save your podcasts
Or


Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
By Johns Hopkins Kimmel Cancer Center4.6
99 ratings
Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.

32,107 Listeners

41 Listeners

6 Listeners

26 Listeners

821 Listeners

4 Listeners

298 Listeners

112,918 Listeners

56,544 Listeners

324 Listeners

45 Listeners

16 Listeners

2 Listeners

25 Listeners

8,179 Listeners

625 Listeners

57,938 Listeners

156 Listeners

808 Listeners